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Autophagy comprises a heterogeneous group of cellular pathways that enables eukaryotic 
cells to deliver cytoplasmic constituents for lysosomal degradation, to recycle nutrients, 
and to survive during starvation. In addition to these primordial functions, autophagy has 
emerged as a key mechanism in orchestrating innate and adaptive immune responses 
and to shape CD4+ T cell immunity through delivery of peptides to major histocompatibility 
complex (MHC) class II-containing compartments (MIICs). Individual autophagy proteins 
additionally modulate expression of MHC class I molecules for CD8+ T cell activation. The 
emergence and expansion of autoreactive CD4+ and CD8+ T cells are considered to play 
a key role in the pathogenesis of multiple sclerosis (MS) and its animal model experimental 
autoimmune encephalomyelitis. Expression of the essential autophagy-related protein 5 
(Atg5), which supports T lymphocyte survival and proliferation, is increased in T cells 
isolated from blood or brain tissues from patients with relapsing-remitting MS. Whether 
Atgs contribute to the activation of autoreactive T cells through autophagy-mediated 
antigen presentation is incompletely understood. Here, we discuss the complex functions 
of autophagy proteins and pathways in regulating T cell immunity and its potential role in 
the development and progression of MS.
Keywords: autophagy pathways, non-canonical autophagy, multiple sclerosis, eAe/MS, oligodendrocyte death, 
antigen presentation
iNTRODUCTiON
Organisms with subcellular compartmentalization and membrane-bound organelles face constant 
challenges in order to maintain metabolic integrity and homeostasis. Autophagy comprises a set 
of evolutionary conserved catabolic pathways that converge in the guided direction of assigned 
cargo to the endolysosomal system (1–3). At first, autophagy was predominantly recognized for 
its contribution in keeping energy homeostasis, and degradation of aberrant protein aggregates (4, 
5) as well as mediator of development-associated forms of cell death (6). In recent years, however, 
autophagy’s function has exceeded the originally allotted role as a mere protein degradation system 
alongside the proteasomal machinery. In addition to regulating cellular proteostasis and cell death, 
autophagy pathways are increasingly being recognized for actively participating in physiological and 
pathological immune responses. In doing so, autophagy pathways limit intracellular proliferation 
of pathogens (7), restrict secretion of proinflammatory mediators (8), and tweak T cell responses 
by orchestrating both loading and preservation of antigens on and surface-expression of antigen-
presenting molecules (9–12).
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS), 
which is driven by a complex interplay of genetic, environmental, metabolic, and immunological 
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factors. The strong genetic association between MS and the major 
histocompatibility complex (MHC) allele DRB1*1501 suggests 
that CD4+ T cell-mediated antigen responses play a key role in 
its pathogenesis. This notion is supported by the presence of 
clonally expanded T and B cells in MS lesions and cerebrospinal 
fluid samples derived from MS patients (13–15). In this review, 
we will first illustrate the biology of distinct autophagy pathways 
and their function in regulating adaptive immunity in order to 
discuss how the autophagy machinery potentially interferes with 
pathogenic adaptive immune responses in MS.
AUTOPHAGY
Canonical autophagy implicates at least three distinct pathways: 
macroautophagy (MA), microautophagy (MI), and chaperone-
mediated autophagy (CMA) (16). Although all of the above 
mentioned pathways coalesce in the lysosome, they considerably 
differ (albeit showing some overlap), in their means of cargo 
transportation, triggering events, and regulatory factors.
MACROAUTOPHAGY
Macroautophagy, the canonical autophagy pathway sensu strictu, 
is evolutionary conserved from yeast to mammalian cells and 
characterized by highly regulated membrane reorganization pro-
cesses with the subsequent de novo formation of a 0.5–1.5 µm wide 
double-membraned vesicle termed autophagosome (17). Upon 
sequestering neighboring parts of the cytoplasm, the autophago-
some subsequently fuses with lysosomes resulting in enzymatic 
cargo break down (18, 19). The process is partitioned in five 
sequential steps (1. induction/nucleation, 2. elongation, 3. clos-
ing/maturation, 4. fusion, 5. degradation) that are orchestrated by 
hierarchies of autophagy-related genes/proteins (Atgs) and other 
essential components, in a tightly regulated enzymatic cascade 
(16, 20, 21) (Figure 1). Albeit originally identified in yeast, mam-
malian counterparts for many Atgs have been characterized and 
some Atgs are so far exclusively reported in mammalian cells and 
lack yeast orthologs (21). Among all autophagy pathways, MA is 
to date the most extensively investigated one and, depending on 
the target constituent encompasses subentities such as macromi-
tophagy, -pexophagy, -xenophagy, and -lipophagy (21–25).
Atg Machinery and Autophagosome 
Formation
De novo synthesis and maturation of the autophagosome as well 
as the trafficking of such vesicles to and fusion with lysosomes are 
distinctive features of MA in opposition to other autophagy path-
ways. Formation of this typifying vesicle requires approximately 
5–10 min and is under the control of an ever-growing number 
of Atgs (19, 21, 26, 27). The finalized autophagosome is usually 
swiftly turned over but may reach a half-life of 10–25 min (28, 
29). The key proteins that initiate and govern the formation of 
the autophagosome can be assembled in functionally designated 
groups: unc 51-like kinase (ULK) complex (1), the class III 
phosphatidylinositide 3-kinase (PI3K) complex (2), the Atg2/
WD repeat domain phosphoinositide-interacting protein (WIPI) 
complex and the Atg9 cycling system (3), the Atg12-conjugation 
system (4), and the microtubule-associated protein 1 light chain 
3 (LC3)-conjugation system (5) (19, 21, 30).
The autophagosome emanates from the double-membraned 
phagophore (also called isolation membrane), which sequesters 
and closes around designated parts of the cytoplasm to form 
the completed autophagosome. The emergence of said phago-
phore constitutes the induction/nucleation phase. However, 
the exact assembly platform and membrane source for the 
generation of these initial structures are still debated. Similar 
to the pre-autophagosomal structure that is observed adjacent 
to the vacuole in yeast, an autophagosome formation site, rep-
resented by dot-like accumulations of Atgs, has been identified 
in mammalian cells (31). Primary suspect organelles to provide 
membranes include specialized PI3P-enriched endoplasmic 
reticulum (ER) domains coined omegasomes (32). 3D electron 
tomography studies corroborated these results by showing that 
the double-membraned phagophore originates in between two 
protruding ER flaps. The phagophore then entwines one of 
the two extensions and finally buds off the ER containing the 
previously enfolded ER flap. This model is further supported 
by the fact that >70% of autophagosomes contain ER-derived 
cargo (33, 34). Nevertheless, other membrane sources for 
autophagosome generation have been suggested. Among them 
is the outer mitochondrial membrane (35). These two opposing 
results might be brought together by a recent study that identi-
fied ER-mitochondria contact sites as the originating platform 
for the autophagosome initiation (36). The VAMP3-dependent 
heterotypic fusion between early endosome-derived Atg9+ 
vesicles and recycling endosome-derived Atg16L1+ vesicles has 
also been suggested to contribute to autophagosome precursor 
generation (37). Additionally, ER exit sites (38, 39), the ER-Golgi 
intermediate compartment together with coat protein complex II 
(40, 41), the plasma membrane (42), and a novel compartment 
comprised of Atg9+ vesicles and tubules (43) were implicated in 
providing membrane material. It is conceivable that different 
subentities of MA preferentially harness distinct membrane 
sources. Possibly, there is a hierarchy of membrane reservoirs 
that sequentially may serve as alternative when other sources 
have been exploited. Furthermore, various tissues with specific 
composition of subcellular compartments may differ in their 
means to utilize membranes for autophagosome generation.
The Atg Core Machinery
The ULK complex is an upstream Atg-unit and, by differential 
phosphorylation of ULK1 (the main mammalian ortholog to 
yeast Atg1), a direct target of MA regulation via target of rapa-
mycin complex 1 (TORC1) and AMP-activated protein kinase 
(AMPK), respectively (44, 45). ULK1/2 builds a stable complex 
with FIP200, Atg13, and Atg101 (46–48). Not composition of 
the complex itself but rather differential phosphorylation of its 
members procures promotion or inhibition of MA. In a state 
of MA inactivation, TORC1 restrains the process by coordinate 
phosphorylation of ULK1/2 and Atg13. During activation, 
MA-promoting phosphorylation of ULK1/2 via AMPK, ULK1/2 
autophosphorylation, and ULK1/2-mediated phosphorylation of 
Atg13 and FIP200 occur followed by translocation of the entire 
FiGURe 1 | Autophagy pathways converge in the lysosomal compartment. Macroautophagy (MA): the phagophore emanates most likely from endoplasmic 
reticulum-derived membrane sources at a PI3P-rich (not depicted) structure called the omegasome. Upon recruitment of microtubule-associated protein 1 light 
chain 3 (LC3) on the outer and inner leaflet of the forming autophagosome, cytoplasmic cargo is engulfed and LC3 removed from the outer membrane as the 
autophagosome is closed. The completed vesicles may now either be further matured via step-wise fusion with the endocytic compartment resulting in the 
generation of amphisomes or immediately fuse with hydrolytic enzymes-containing lysosomes. Chaperone-mediated autophagy: target proteins that contain an 
exposed KFERQ sequence motif are guided in an hsc70-dependent manner toward lysosome-associated membrane protein type 2A (LAMP-2A), which resides in 
the lysosomal membrane. Upon unfolding of the target protein, LAMP-2A multimers together with lysosomal hsc70 facilitate the transport into the lysosomal lumen. 
LC3-associated phagocytosis: ligation of an appropriate receptor (e.g., TLR2, Dectin-1, TIM4, etc.) leads to receptor-mediated phagocytosis recruitment and 
binding of LC3 to the outer membrane of the LAPosome. By analogy with the MA pathway, completed LAPosomes may either fuse with other endocytic vesicles or 
directly merge with lysosomes. Microautophagy: cytoplasmic cargo can be directly targeted to endosomal compartments/multivesicular bodies (MVB) in an hsc70-, 
phosphatidylserine (Ptd-L-Ser)-, and endosomal sorting complexes required for transport (ESCRT)-dependent manner. Exosomes containing cytoplasmic material 
may emanate from the MVB and be secreted into the extracellular space. The molecular events and regulatory processes orchestrating the direct invagination of 
cytoplasmic constituents into lysosomes remain largely unbeknownst.
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complex to autophagosomal initiation sites possibly on tubulov-
esicular areas comprised of ER and Atg9+ vesicles (46, 49–52). 
Atg101 may facilitate phosphorylation of Atg13 and minimize its 
proteasomal degradation (53, 54).
The Class iii Pi3K Complex
The tetrameric core of this complex consists of vacuolar protein 
sorting protein (Vps)34 (a phosphoinositide 3 kinase), Vps15 (a 
regulatory subunit of Vps34 also called p150), Beclin 1 (ortholog 
of Atg6), and Atg14L (aka Atg14 and Barkor) (27, 55, 56). NRBF2 
(ortholog of Atg38) is a recently identified additional subunit of 
the complex that augments the enzymatic activity of the lipid 
kinase Vps34 (57–59). The lipid kinase complex is recruited to 
autophagosomal initiation sites in an ULK1-complex/Atg9-
dependent manner (31, 60).
The key function of the complex is to produce PI3P via Vps34-
mediated phosphorylation of phosphatidylinositol. Presence and 
accumulation of PI3P are essential for MA as PI3P-enriched 
membrane areas then function as platforms to which downstream 
PI3P-binding partners can be recruited. Regulation of MA occurs 
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also on the level of the PI3P complex in that death-associated 
protein kinase promotes autophagosome formation by unleash-
ing Beclin 1 from the Bcl-2/Bcl-XL complex (61).
Atg2/wiPi Complex and the Atg9 Cycling 
System
WIPI1/2 (mammalian ortholog to yeast Atg18) and its binding 
partner Atg2 are among the PI3P-binding effector molecules 
that are recruited to PI3P-enriched sites upon PI3PK complex 
activation (31, 62–64). Since PI3P is present on various subcel-
lular membranes, up until recently it remained a conundrum as of 
how organelle-specific WIPI-binding is achieved. Studies in yeast 
have now suggested that WIPI-recruitment to the phagophore 
requires a dual determinant: PI3P as well as presence of Atg2 (65). 
The Atg2/WIPI complex is thought to be downstream of the two 
previous complexes but lateral to the following two conjuga-
tion systems (21). Its presence is essential for the formation of 
autophagosomes probably in part due to recruitment of lipidated 
LC3 (mammalian ortholog of yeast Atg8) to autophagosomal ini-
tiation sites and shielding of lipidated LC3 from Atg4-mediated 
deconjugation (66).
The transmembrane protein Atg9 can be found in the trans-
Golgi network and on late endosomes under nutrient-rich 
(hence MA-inactive) conditions (67). Upon starvation (and 
induced MA activity) however, Atg9+ vesicles translocate from 
the trans-Golgi network and colocalize with LC3 (67). Possibly, 
Atg2 and WIPI1/2 mediate Atg9-shuttling between autophago-
somal initiation sites and peripheral membrane sources (68). 
However, its interaction and association with the autophago-
some appear to be transient since completed autophagosomes 
are devoid of Atg9 (69). It was also suggested that local fusion 
of Atg9+ vesicles operates as an initiation step in the generation 
of autophagosomes (43). Possibly, Atg9 functions in provision 
of membrane material for generation of autophagosomes or 
even removal of early autophagosomal molecules from the site 
of autophagosome generation (21). The exact interplay between 
the individual molecules of this unit and their overall function 
remains subject to further investigation.
The Atg12-Conjugation System
The first of two ubiquitin-like conjugation systems that orches-
trate autophagosome formation consists of the MA-essential mol-
ecules Atg12, Atg7, Atg10, Atg5, and Atg16L1 (21). Constitutively 
and independent of cellular nutrient status, Atg12 is activated via 
E1-like enzyme Atg7, followed by transfer to E2-like enzyme 
Atg10 which catalyzes the covalent conjugation of Atg12 to Atg5. 
Via binding to Atg5, the conjugate then forms a complex with 
Atg16L1 (70). WIPI2 now attracts the Atg5–Atg12–Atg16L1 
complex by means of a recently identified binding site in Atg16L1 
to the site of autophagosome generation (71). Additionally, it has 
been suggested that Atg16L1 is also recruited to the phagophore 
via binding to ULK-complex member FIP200 (72, 73). On site, 
the complex then functions as an E3-like enzyme for the second 
conjugation system. The complex is regularly found on the outer 
membrane of the phagophore but dissociates from there upon 
completion of the autophagosome (26).
The LC3-Conjugation System
The second and final conjugation system is comprised of the 
ubiquitin-like LC3, the hydrolase Atg4, Atg7, and Atg3, which 
function as E1- and E2-like enzymes, respectively. The pro-form 
of LC3 is cleaved by Atg4 leading to exposure of a C-terminal 
glycine residue (74, 75). The resulting LC3-I is then lipidated 
with phosphatidylethanolamine (PE) at said glycine residue by 
means of Atg3 and Atg7 (76–78). This PE-lipidation of LC3 is 
assisted by the Atg5–Atg12-conjugates via E3-like activity (70, 
79). Additionally, the Atg5–Atg12–Atg16L1-complex guides and 
determines LC3 to its subcellular destination (79). This lipidated 
form of LC3, also called LC3-II is initially found symmetrically 
distributed on the inner and outer membrane of the phagophore 
(75, 76, 80). There it appears to aid in elongation of the phagophore 
as well as coordinate tethering and hemifusion of its membranes 
and finally the closing of the phagophore to an autophagosome 
(81–84). Upon vesicle closure, LC3 on the outer membrane is 
being cleaved from PE via Atg4 while intraluminal LC3 stays 
associated with the organelle which makes LC3-II to this day a 
valuable marker for autophagosomes (80, 85). In addition to its 
contribution during membrane reorganization, LC3 mediates 
MA-cargo selectivity by functioning as an adaptor molecule (86).
ReGULATiON OF MA
Most mammalian cells carry out MA on a constitutive level at 
varying degrees. However, depending on the cell type, macro-
autophagic activity can be induced and modulated in numerous 
ways. Primarily nutrient deprivation is a potent stimulus of 
autophagy and starvation-induced autophagy is a common 
means to investigate MA under experimental conditions (87, 88). 
The process receives regulatory input on both a systemic and a 
cellular level (88). Among the most upstream regulatory units 
of the MA machinery is the antagonistic interplay of coordinate 
phosphorylation by the two serine/threonine protein kinases 
AMPK and TORC1 (44, 45) (Figure 2). For insights into tran-
scriptional and epigenetic regulation of MA, we kindly refer the 
reader to excellent recent review articles (89–91).
mTOR/TORC1
Target of rapamycin complex 1 is one of two functional units of 
mTOR. Notably, as opposed to TORC2, which has been implicated 
as an inhibitory entity of CMA activity (92), TORC1 is actually 
a binding partner for the eponymous rapamycin and is the rel-
evant subunit that participates in negatively regulating MA (93). 
Various signals that reflect a cell’s metabolic status (free amino 
acids, growth factors, fatty acids, oxygen, etc.) are integrated at 
the level of TORC1 which, during its activated state, restrains MA 
via phosphorylation of the upstream MA-machinery members 
ULK1/2 at serine 757 and ATG13 at serine 258 and is therefore 
considered a potent negative regulator of MA (46, 47, 94). In 
keeping with its cardinal function as a coordinator of metabolic 
homeostasis, two major inputs for TORC1 downstream signal-
ing are free amino acids and growth factors (88). Growth factors 
signal via the PI3K–Akt–tuberous sclerosis complex (TSC)1/
TSC2 pathway, eventually leading to disinhibition of the small 
FiGURe 2 | Regulatory network of macroautophagy (MA). This figure illustrates the most important regulatory interplay of molecules that govern MA activity. 
Growth factors can signal through phosphatidylinositide 3-kinase (PI3K) to Akt, which in turn inhibits the Beclin 1-containing class III PI3K complex. Akt may also 
repress transcription of autophagy-promoting genes by direct inhibition of transcription factor forkhead box protein O3 (FoxO3). Additionally, Akt reduces 
macroautophagic activity by inhibiting tuberous sclerosis complex (TSC)1/TSC2. Akt interaction with PRAS40 promotes mTORC1 activity thereby further damping 
MA. The calcium/calmodulin (Ca2+/CaM) serine/threonine kinase death-associated protein kinase (DAPK) fosters MA through phosphorylation of Beclin 1 at T119 
which leads to dissociation of Beclin 1 from Bcl-2. The TSC1/TSC2 complex can promote MA by inhibiting the mTORC1 activator and GTPase Ras homolog 
enriched in brain (Rheb). AMPK and mTORC1 are the two cardinal regulatory units that control MA. mTORC1 may repress the process by phosphorylation of 
ULK1/2 and/or Atg13. mTORC1 activity is increased by amino acid sensing Rag GTPases via interaction with Raptor. The Rag GTPases also facilitate translocation 
of mTORC1 to the lysosomal membrane, which serves as a prerequisite for the aforementioned mTORC1-promoting activity of Rheb. AMPK promotes MA by 
several means: phosphorylation of ULK1/2 and/or Atg13 at different residues than mTORC1, direct interaction with FoxO3, and by directly disinhibiting the inhibitory 
units, mTORC1 and Raptor. AMPK itself can be triggered by increasing levels of AMP relative to ATP, free Ca2+, and activity of liver kinase B1 (LKB1), transforming 
growth factor-β-activating kinase 1 (TAK1), and CAMKK2.
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GTPase Ras homolog enriched in brain (Rheb) which then 
directly activates TORC1 (95–97). Alternatively, the mTOR bind-
ing partner proline-rich Akt/PKB substrate 40 kDa (PRAS40) is 
directly phosphorylated by Akt which in turn leads to revoking 
of PRAS40-mediated inhibition of mTOR (98). Recently, Akt has 
been shown to also hamper MA in a direct manner via phos-
phorylation of Beclin 1 (99). Indirectly, Akt may repress MA via 
inhibiting forkhead box protein O3 (FoxO3) members-dependent 
transcription of autophagy-promoting genes (100–102).
Target of rapamycin complex 1 does not directly detect free 
amino acids and the actual amino acid sensing entity remains yet 
to be identified (88). Detection of free amino acids by innomi-
nate cytoplasmic sensors facilitates the Rag-GTPases-dependent 
translocation of TORC1 to the lysosomal membrane, which is a 
spatial requirement for Rheb-mediated activation of TORC1 (88, 
103, 104).
AMPK
AMPK is primarily an energy-sensing kinase that in response 
to metabolic stress and depleted cellular energy resources such 
as a low ATP:AMP ratio initiates catabolism (105). In doing so, 
AMPK is also a positive regulator of MA-mediated proteolysis 
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(106). However, even under nutrient-rich conditions AMPK 
may act toward MA induction in a Ca2+-dependent manner 
(107, 108). Although essential for starvation-induced MA, 
AMPK might not suffice as a stand-alone signal but is likely 
to require additional cues in order to fully initiate MA (107, 
108). Liver kinase B1, calcium/calmodulin-dependent protein 
kinase kinase-β (CAMKKβ), and transforming growth factor-β-
activating kinase 1 are upstream regulators which through phos-
phorylating its catalytic α-subunit activate AMPK (109–113).
AMPK promotes MA by different pathways such as initiation 
of Rheb inhibition through TSC1/TSC2 (114), phosphorylation 
of the mTOR binding partner raptor, thereby inhibiting TORC1 
(115), or direct phosphorylation of ULK1/2 (at serine 317 
and serine 777) or Atg13 (at serine 224) which activates these 
family members of the upstream MA machinery (44, 45, 94). 
Furthermore, AMPK positively regulates MA through activation 
of the transcriptional factor FoxO3 which in turn transactivates 
MA-essential genes (116, 117).
MiCROAUTOPHAGY
During MI, a vaguely characterized autophagosome-independ-
ent process, superfluous cytoplasmic constituents including 
whole organelles are directly engulfed by surface invaginations 
of lyso- or endosomal surfaces leading to the budding of cargo-
containing microvesicles into the endolysosomal lumina where 
degradation takes place (118–121) (Figure 1). MI initially has 
been termed unselective; however, numerous reports in yeast 
and mammalian cells challenged this concept and described 
more discerning mechanisms and functions underlying this 
pathway (118, 120, 122). For instance, the MI-assisted transport 
of endosomes to lysosomes appears to be a crucial event during 
murine embryogenesis in a Rab7-dependent manner (123). 
Endosomal sorting complexes required for transport (ESCRT)-
machinery-dependent microlipophagy is essential during cel-
lular adaptation to cell stress caused by disruption of lipidostasis 
in yeast (124). Schuck and colleagues characterized the specific 
uptake of compromised ER into the yeast vacuole and coined the 
term ERphagy (125). Other cargo selective MI entities in yeast 
include micromitophagy (126, 127), micropexophagy (128, 
129), and piecemeal microautophagy of the nucleus (130–132). 
To which extent these processes take place in mammalian cells 
remains largely obscure (133). Little is known about MI and its 
regulation on a molecular level in mammalian cells and most 
findings rely on electron microscope-based morphological 
alterations such as lysosomal wrapping and flap-like lysosomal 
membrane extensions (133). The picture becomes even more 
hazy when acknowledging that some forms of MI require the 
core machinery needed for MA (see above) but others do not 
(120, 128, 132, 134). However, distinct cargo selective MI path-
ways have also been identified in mammalian cells. For instance, 
heat shock cognate protein of 70  kDa (hsc70)-dependent tar-
geting of cytosolic KFERQ sequence motif-containing proteins 
into late endosomes and multivesicular bodies (MVB), termed 
endosomal MI, has recently been identified in murine antigen-
presenting cells (APCs) (120). Although this newly characterized 
process resembles the selective pathway of CMA (see below) 
into lysosomes, this endosome/MVB-destined MI does not 
require unfolding of target proteins and is lysosome-associated 
membrane protein type 2A (LAMP-2A) independent (120). 
Also different from CMA, endosomal MI is not only dependent 
on hsc70 but also heavily relies on ESCRT I and III and involves 
electrostatic binding of hsc70 to negatively charged endosomal 
phosphatidylserine (Ptd-L-Ser) (120, 135). Fission yeast Nbr1, 
a partial homolog of mammalian MA receptor NBR1, has been 
recently identified as a receptor for ESCRT-dependent endoso-
mal MI (136, 137). Two recent reports further elaborated on this 
novel pathway. Mukherjee and colleagues describe an endoso-
mal MI-like process in the fat body of Drosophila melanogaster. 
In accordance with what had been reported previously, this 
process is KFERQ- and hsc70-dependent and relies on ESCRT 
I-, II-, and III-mediated endosomal MVB formation. Although 
this pathway is independent of MA-machinery members—atg5, 
atg7, and atg12—it can be induced by prolonged starvation 
and by mTOR signaling under nutrient-rich conditions (138). 
A second report shows that by means of its oligomerization 
capabilities, hsc70 promotes membrane deformations, which 
supports presynaptic endosomal MI and increases the local 
turnover of target proteins. Importantly, the degree of presyn-
aptic endosomal MI fosters the release of neurotransmitters into 
the synapse (139).
Intraluminal vesicles generated within MVBs give rise to 
exosomes which in a controlled and coordinated manner are 
released to the extracellular space by most cells (140, 141). 
Aside from their physiological function in cell-to-cell com-
munication and coordinating immune responses, these vesicles 
of endocytic origin have also been implicated in propagating 
neurodegenerative processes (141–143). Conclusive evidence 
points toward a substantial role of endosomal MI in providing 
cargo for this unique secretory pathway (120, 141). It will be of 
great importance to elucidate the mechanisms and triggers that 
decide whether MVB content is targeted toward intracellular 
degradation by the lysosome or instead is fed into the secretory 
pathway via exosomes.
CHAPeRONe-MeDiATeD AUTOPHAGY
Chaperone-mediated autophagy is a selective degradation pro-
cess devoid of autophagosome formation during which substrate 
proteins are directly targeted to the lysosome (144) (Figure 1). 
There is no known equivalent in yeast and evolutionary speaking 
CMA has emerged only recently, thus far exclusively being iden-
tified in mammals (145). Most cells constitutively carry out CMA 
but the process is upregulated in response to oxidative stress 
(146), hypoxia (147), DNA damage (148), or protracted nutrient 
deprivation (149). Unlike MI and MA, which may also handle 
surplus organelles and non-protein macromolecules, CMA 
exclusively processes proteins that contain a pentapeptide motif 
in their amino acid sequence (KFERQ) (150). CMA encompasses 
at least five distinct steps (1. recognition, 2. binding, 3. unfold-
ing, 4. translocation, 5. disassembly) (144): target proteins bind 
with their KFERQ-recognition motif to the cytosolic chaperone 
hsc70 and the substrate:chaperone complex translocates to the 
lysosomal membrane (recognition) (151). There, LAMP-2A, a 
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CMA-receptor, binds the substrate:chaperone complex via its 
cytosolic tail and subsequently the designated protein undergoes 
unfolding in a hsc70-dependent manner probably assisted by 
co-chaperons on the cytosolic side of the lysosome (binding 
and unfolding) (152, 153). Binding of the substrate:chaperone 
complex to monomeric LAMP-2A not only initiates protein 
unfolding but also recruitment of further LAMP-2A molecules 
and subsequent assembly of high molecular weight multimers 
that then, by help of lysosomal hsc70 (lys-hsc70) enable passage 
of target proteins to the luminal side of the lysosome (transloca-
tion) (154). Upon release of the target protein into the lysosomal 
lumen, the LAMP-2A multimers are hsp70-dependently broken 
down into monomers which are then available for another cycle 
of ligand binding and uptake (disassembly) (154). Recently, 
more light has been shed on the molecular regulatory pathways 
controlling CMA. Glial fibrillary acidic protein (GFAP) together 
with elongation factor 1α tunes assembly and disassembly of the 
LAMP-2A translocation complexes at the lysosomal membrane 
(155). Phosphorylation of GFAP by lysosomal Akt1 leads to 
destabilization of such translocation complexes and consequently 
reduced CMA activity. The antagonistic interplay between PH 
domain leucine-rich repeat-containing protein phosphatase 1 
(PHLPP1) as a negative and mTORC2 as a positive regulator 
upstream of lysosomal Akt1 signaling therefore appears to play 
a central role in modulating CMA activity (92). Different from 
MI and MA, CMA processes one molecule at the time and does 
not require morphological changes of lysosomal membranes 
such as invaginations, wrapping, flap-like extensions, or fusion 
with other membranes (156, 157). The main rate limiting factor 
in CMA is abluminal LAMP-2A availability which is regulated 
by the degree of LAMP-2A degradation by a metalloprotease and 
cathepsin A at the site of designated lipid microdomains in the 
lysosomal membrane (158). As previously mentioned, a prereq-
uisite for CMA processing of a target protein is the presence of 
an amino acid sequence motif biochemically related to KFERQ 
(150). In contrast to the biochemical earmarking of a molecule by 
means of ubiquitination, which may designate the target for pro-
teasomal degradation or recognition by ubiquitin-recognizing 
adaptor molecules, the KFERQ consensus motif is pre-existing 
in CMA-target proteins (145). It is therefore likely that the 
pentapeptide motif is not ubiquitously accessible for binding to 
hsc70 in order to prevent premature protein translocation to the 
lysosomal lumen via CMA. Possible mechanisms to condition a 
target for this destination include but are not limited to, partial 
unfolding, disassembly of multimers, cleavage of proteins, and 
posttranslational modifications such as phosphorylation or 
acetylation of amino acid residues (145, 159, 160). Cytosolic 
accumulation of aberrant proteins is a hallmark of age-related 
proteinopathies of the brain and other tissues. A central func-
tion of CMA is the removal of misfolded or unwanted proteins 
and dysfunction in CMA in senescent cells has been implicated 
in promoting neurodegeneration (161–163). Not considering 
posttranslational alterations, roughly 30% of cytosolic proteins 
bear a sequence motif biochemically related to KFERQ and 
are therefore potentially subject to CMA-mediated lysosomal 
degradation (145, 150, 151). Due to the heterogenous nature of 
this protein pool it does not come as a surprise that CMA can 
be regarded as a pivotal gatekeeper in energy homeostasis that 
also fine-tunes vital cellular processes by limiting key metabolic 
enzymes (144).
AUTOPHAGOSOMe MATURATiON AND 
FUSiON wiTH THe eNDOLYSOSOMAL 
SYSTeM
A hallmark of all autophagic pathways is their convergence 
into the lysosomal system. During MA, this event requires 
the coordinated membrane fusion of the autophagosome and 
endolysosomal vesicles (Figure 1). Prior to terminal fusion with 
lysosomes, autophagosomes may (or may not) fuse with vesicles 
of the endocytic compartments like early or late endosomes. The 
resulting amphisomes subsequently fuse with lysosomes to form 
autolysosomes. These partly sequential, partly parallel fusion 
events underscore the dynamic nature of MA. Hence, observed 
accumulation of autophagosomes needs to be carefully inter-
preted, for it can mean both bona fide induction of the process 
and blocked lysosomal fusion.
Autophagosomes are widely distributed throughout the 
cytoplasm. For these vesicles to fuse with lysosomes and late 
endosomes (which are predominantly located juxtanuclear), 
autophagosomes need to be efficiently guided toward this area. 
Members of the cytoskeleton have been shown to orchestrate 
the regulated trafficking of autophagosomes from the periphery 
to sites at which membrane fusion occurs. In fact, microtubules 
might even aid in autophagosome formation and subsequent 
fusion with endosomal compartments (164, 165). In an antago-
nistic interplay, the members of the motor protein family dynein/
dynactin complex and kinesin have shown to be involved in guid-
ing autophagosomes alongside microtubules toward lysosome-
rich areas, a process during which the trafficked vesicles become 
increasingly acidified as they approach the juxtanuclear area (166, 
167). Consequently, disruption of the dynein machinery exac-
erbates aberrant protein aggregation in experimental models of 
neurodegeneration due to dysfunctional MA (168). Interestingly, 
dynamic distribution of lysosomes within the cytoplasm may 
actually constitute a mechanism by which autophagic flux is 
regulated (169).
In accordance with general membrane reorganization, also 
the fusion of autophagosomes with endolysosomal vesicles 
is in large parts orchestrated by members of small GTPases 
called Rabs, membrane-tethering complexes, and SNAREs. The 
molecular specifics have been reviewed in detail elsewhere (170, 
171). Studies in yeast suggest that Atg4-mediated cleavage of the 
LC3 ortholog Atg8 from the outer membrane constitutes one 
prerequisite that renders the autophagosome ready for fusion 
(172, 173). Possibly, absence of molecules that are involved in the 
early phase of autophagosome biogenesis functions as yet another 
signal (170).
Our understanding of the precise molecular events during 
autophagosome biogenesis and fusion has significantly improved 
during the last decade and enticing models have been proposed 
as on how the phagophore is initiated. However, one needs to 
be cautious as of how the aforementioned molecular interplay of 
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Atgs can be generalized since most results were obtained studying 
starvation-induced MA. There is evidence that autophagosomal 
biogenesis, and subsequent fusion partners, -sites, and -mecha-
nisms are highly dependent on induction stimulus and cargo 
(170). Furthermore, the degree as to which these processes are 
actually carried out in sequence remains enigmatic. It is likely 
that numerous steps occur in parallel and distinct Atgs might not 
only carry out a single function but take on several tasks within 
the cascade. The molecular interactions between Atgs and the 
kinetics of the process might also significantly differ within the 
mammalian species and even on a tissue level, there might be 
specifics to MA that need to be taken into account.
Finally, at least for some Atgs that are essential for MA, an even 
more promiscuous role has begun to unfold in that these proteins 
also facilitate MA-independent functions in cellular reprogram-
ing, dynamic membrane re-distribution, pathogen clearance, and 
antigen presentation (11, 174–178).
NON-CANONiCAL AUTOPHAGY 
PATHwAYS
Non-canonical autophagy comprises a set of recently char-
acterized pathways that either result in autophagosome 
formation but omit the usage of distinct parts of the classical 
MA-machinery or autophagosome-independent pathways that 
utilize key components of the MA network (16, 179). One can 
at least differentiate five distinct entities: LC3-associated phago-
cytosis (LAP), Beclin 1-independent autophagy, autophagosome 
formation from multiple phagophores and pathogen-specific 
autophagy modification, autophagy-associated unconventional 
protein secretion, and defective ribosomal products-containing 
autophagosome-rich blebs. Here, we focus on LAP, since this 
pathway has been associated with antigen processing and 
presentation, and kindly refer the reader for specifics on the 
other non-canonical autophagy pathways to excellent reviews 
elsewhere (16, 179, 180).
LC3-Associated Phagocytosis
During phagocytosis, a specialized way of endocytosis, cells 
internalize solid extracellular constituents in a receptor-mediated 
fashion. The resulting phagosome is being step-wise matured 
and subsequently fuses with the lysosomal compartment in 
order to break down the incorporated material (181). Recently, 
a novel organelle, the single-membraned LC3+ phagosome or 
LAPosome, has been identified and the process of its generation 
and fate was coined LAP (Figure 3) (182, 183). LAP, that links 
both phagocytosis of extracellular cargo and members of the 
autophagy molecular core machinery, is initiated by ligation of 
a variety of extracellular receptors (12, 182, 184–186). Although 
some components of the MA machinery are essential for LAP 
(e.g., Atg5, Atg7, LC3, Beclin 1), the process is independent of 
others (e.g., the ULK complex including ULK1/2, FIP200, Atg13, 
Atg101, WIPI1).
LC3-associated phagocytosis-triggering receptors include 
toll-like receptors (TLRs), Fc-receptors, C-type lectins, and Ptd-
L-Ser-binding receptors (12, 182, 184–186). Upon activation of 
a LAP-triggering surface receptor, a PI3PK complex that differs 
in its composition from the one involved in MA, is recruited 
to the cytosolic membrane of the phagosome followed by the 
recruitment of the NADPH oxidase NOX2. These events are not 
preceded by involvement of the canonical ULK complex. The 
LAP-associated PI3PK complex is made up by Beclin 1, Vps34, 
and Vps15 (analogous to MA) but is devoid of Atg14 (187). 
Instead, it includes UVRAG and Rubicon (not members of the 
canonical PI3PK complex). Similar to MA, the PI3PK complex is 
set out to generate PI3P on the LAPosome. The association of the 
modified PI3PK complex on the LAPosome is potentially liaised 
via Rubicon which, together with PI3P also appears to be key in 
recruiting, stabilizing, and activating the NADPH oxidase NOX2 
to the organelle (187). Rubicon mediates NOX2 stabilization by 
interaction of its serine-rich domain (AA 567–625) with the NOX2 
subunit p22phox whereas PI3P stabilizes the NOX2 subunit p40phox 
(187, 188). LAPosomal PI3P in concert with NOX2-dependent 
reactive oxygen species (ROS) production then initiates the two 
canonical MA conjugation systems (see above), which results in 
efficient deposition of lipidated LC3 on the outer LAPosomal 
membrane (187). Consequently, LAP is highly dependent on the 
MA proteins Atg5, Atg12, Atg16L1, Atg7, Atg3, Atg4, and lipi-
dated LC3. Molecules that have been described to be dispensable 
for canonical MA but are thought to be essential for LAP include 
NOX2 and Rubicon (187).
Taken together and in contrast to the canonical MA pathway, 
during which LC3 conjugation to the phagophore allows for 
recruitment of cytoplasmic substrates into forming autophago-
somes by means of LC3-binding anchor proteins such as p62/
sequestosome 1, LAP handles formerly extracellular particles 
that access the cell through phagocytosis and occurs without the 
formation of a double-membraned vesicle and in the absence of 
p62/sequestosome 1 on LC3+ single-membraned phagosomes 
(179, 183, 187).
So far LAP has been implicated in efficient clearance of 
Saccharomyces cerevisiae and Aspergillus fumigatus (182, 187). 
However, in the case of Listeria monocytogenes infection, 
LAPosomes have been described as Listeria-containing compart-
ments that promote persistent infection (189). In plasmacytoid 
dendritic cells (DCs), LAP, induced upon binding of immune 
complexes through FcγR, is required to assemble the interferon 
regulatory factor 7 (IRF7)-signaling compartment which is 
essential for IRF7 activation and subsequent IFNα secretion 
downstream of TLR9 ligation (186). LysM-Cre+ conditional 
knockout mice for LAP-essential proteins mainly target CD11b+/
F4/80+ macrophages and CD11b+Ly6G+ neutrophils. Aged mice 
that are deficient of LAP activity in these myeloid subsets sponta-
neously acquire a lupus-like phenotype (190).
Several questions remain unanswered. The functional benefit 
of coupling lipidated LC3 to a phagosome is still not completely 
understood. Some have argued that the coating of the phagosome 
with LC3-II allows the vesicle to travel faster along microtubules 
which results in faster fusion with the lysosomal compart-
ment (182, 185, 191). However, studies that report more rapid 
cargo degradation were predominantly obtained using murine 
macrophages. Human studies on the other hand show that in 
prototypical APCs such as DCs, LAP seems to retain antigenic 
FiGURe 3 | Microtubule-associated protein 1 light chain 3 (LC3)-associated phagocytosis. The ligation of LC3-associated phagocytosis (LAP)-triggering 
receptors such as phosphatidylserine (Ptd-L-Ser)-recognizing TIM4, TLR2, Dectin-1, or Fcγ receptors will ensue receptor-mediated phagocytosis and subsequent 
phosphatidylinositide 3-kinase-dependent association of the NADPH oxidase NOX2 with the phagosome. The NOX2-derived reactive oxygen species (ROS) and 
laposomal PI3P (not depicted) mediate the recruitment and binding of LC3 to the outer membrane of the LAPosome. Instead of terminal fusion with the lysosomal 
compartment, the completed LAPosome may also fuse with endosomal vesicles including major histocompatibility complex (MHC) class II-containing compartments 
(MIICs) in which after enzymatic digestion, LAPosomal content can be loaded upon MHC class II molecules followed by the presentation of the resulting peptides to 
TH cells.
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cargo for sustained MHC class II antigen presentation rather than 
promoting its degradation (12). Antigenic containment and sta-
bilization in combination with low levels of lysosomal proteases 
have been speculated to be a crucial mechanism by which DCs 
maintain efficient and prolonged antigen presentation (12, 183, 
192). Lee and colleagues reported that in murine DCs, TLR-
dependent phagocytosed HSV-2 can be found in LC3+ single-
membraned vesicles reminiscent of LAPosomes. In absence of 
LAP-essential protein Atg5, subsequent HSV-2-specific CD4+ 
T cell responses were markedly reduced, arguing for inefficient 
MHC class II-dependent presentation of LAP-deficient DCs 
toward cognate T cells (193). Interestingly, pharmacological 
induction of canonical MA by TORC1 inhibitor rapamycin did 
not lead to enhanced MHC class II presentation of viral antigens 
arguing for a non-MA pathway linking phagocytosis and MHC 
class II presentation (193).
AUTOPHAGY PATHwAYS iN CNS 
AUTOiMMUNiTY
Multiple sclerosis is a chronic neuroinflammatory condition dur-
ing which autoaggressive leukocytes invade across a compromised 
blood–brain barrier into the CNS. On site, the infiltrated immune 
cells, in concert with CNS-resident cells mediate progressive 
axonal demyelination and engender spatio-temporally dissemi-
nated lesions within the CNS which entails diffuse cytodegenera-
tion in gray and white matter areas of the CNS (194) (Figure 4).
Experimental autoimmune encephalomyelitis (EAE) is a com-
monly used animal model of MS in which disease is induced by 
immunization of animals with myelin-derived antigenic peptides 
together with adjuvant or by adoptively transferring pre-activated 
myelin-specific CD4+ T cells in naïve recipients (195–197). EAE 
is a predominantly T cell-driven model and a pathomechanistic 
FiGURe 4 | Multiple sclerosis (MS) pathogenesis. Sequence of events that initiates the onset of disease (1–5). MS is suspected to be an autoimmune 
condition during which peripheral autoaggressive T cells cross into the central nervous system (CNS) where, in concert with other leukocytes, they mediate 
axono-oligodendroglial damage and unleash a circle of self-perpetuating neuroinflammation (1–5). An alternative to this “outside-in” sequence is the “inside-out” 
model, which proposes a primary disease triggering event within the CNS (I–IV): primary oligodendrocyte damage of unknown cause may lead to dying and 
disintegrating oligodendrocytes followed by the uptake of myelin-derived material by CNS-resident antigen-presenting cells (APCs). Upon further intracellular 
processing of the phagocytosed material, APCs present antigenic myelin-derived peptides to TH cells (at an as of yet unknown site) which in turn initiate influx of 
peripheral immune cells by secretion of proinflammatory cytokines and chemokines. On site, infiltrating immune cells, including cytotoxic CD8+ T cells and myeloid 
cells perpetrate secondary oligodendrocyte damage.
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prerequisite for CNS damage is the local reactivation of CD4+ T 
cells specific for myelin-derived antigens (198–202). Reactivated 
CD4+ T cells together with activated myeloid cells initiate a cas-
cade of proinflammatory events, which is believed to perpetuate 
CNS tissue damage leading to the development of clinical EAE 
symptoms (203–205).
How and by which APC subset pathogenic CD4+ T cells are 
being locally reactivated and cause tissue damage during the 
course of MS and EAE is, however, incompletely understood. This 
is in part due to the fact that the detailed antigen-processing route 
of how myelin self-antigens are processed and presented toward 
CD4+ T cells has not been fully elucidated.
Given their diverse, yet often essential functions in immune 
surveillance, cell survival, proteostasis, antigen presentation, and 
regulating cellular energy levels, a role for autophagy pathways 
in the complex pathobiology of MS can been proposed in many 
aspects of the condition including but not limited to the innate 
and adaptive branches of the immune system. In the following 
sections, we will discuss how autophagy pathways potentially 
interfere with pathogenic adaptive immune responses in MS.
AUTOPHAGY iN T CeLLS
Autophagy has a central but complex role in cell survival in 
numerous cell types, functioning either as a pro-survival or as a 
cell death mechanism depending on the cell type, the nature of 
the death stimulus, and subsequent compensatory changes. Atg5-
deficient CD4+ and CD8+ T cells develop normally in the thymus, 
but fail to repopulate the periphery because of massive cell death 
and fail to undergo efficient proliferation after T cell receptor 
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stimulation (206). Using a T cell-specific conditional knockout 
of Beclin 1 (CD4-Cre Beclin 1fl/fl), Kovacs et al. later elaborated 
on the underlying mechanism and confirmed that in absence of 
Beclin 1 in the CD4+ CD8+ T cell compartment, homeostasis was 
disturbed. In line with previous reports, thymic development of 
the T cell compartment was normal; however, numbers of CD8+ 
T cells in secondary lymphoid organs were drastically diminished 
(>3-fold), whereas CD4+ T cell were less affected (reduction of 
CD4+ T cell numbers amounted to <2-fold). The steady state 
fractions of naïve and memory T cells were unchanged between 
conditional KO mice and controls. Upon activation with anti-
CD3/anti-CD28, however, T cells readily underwent apoptosis. 
Increased susceptibility to cell death was linked to MA-dependent 
degradation of pro-apoptotic proteins and seems to be differen-
tially relevant in CD4+ T cell subsets (207).
Additionally, Atg16L1-specific deletion in T cells results in 
spontaneous intestinal inflammation and inbalances of different 
TH cell subsets in the gut. While intestinal T regulatory cells 
(TREGs) are drastically reduced in number, IL-13-producing 
TH2 cells expand (208). TREG-specific deletion of Atg5 and Atg7 
entailed reduced frequencies and survival of this subset and leads 
to defective self-tolerance (209).
These data indicate a critical role for the autophagy machinery 
in lymphocyte development and function and suggest that MA 
may be essential for both T lymphocyte survival and proliferation 
in the steady state and after immune activation.
In line with these assumptions, CD4-Cre Beclin 1fl/fl mice 
are completely protected from active induction of EAE (207). 
Interestingly, the defect in the CD4+ T cell compartment dur-
ing EAE is much more pronounced in the TH1 fraction but only 
mildly present in TH17. Subsequent in vitro experiments further 
confirmed that TH1 cells are significantly more prone to undergo 
apoptosis in absence of autophagy (207).
In addition to the observed protection of EAE upon T cell-
specific ablation of autophagy, Atg5 transcript and protein levels 
in circulating T cells positively correlated with the disease score 
in mice that had been actively immunized with MOG35–55 peptide. 
Furthermore, peripheral T cell-derived RNA analyses suggested 
a significant increase in Atg5 expression in patients with active 
relapsing-remitting MS as compared to healthy controls. Atg5 
RNA levels in postmortem brain tissue from patients with 
secondary progressive MS (SPMS) were markedly elevated and 
strong Atg5 immunoreactivity was observed in confocal micros-
copy analyses (210).
In contrast to what Kovacs and colleagues had reported, 
another study that used Beclin 1-deficient Rag1−/− chimeras, 
found that although Beclin 1 is essential for the maintenance of 
early lymphocyte progenitor subsets, it is widely expendable for 
the homeostasis and function of peripheral T and B cells (207, 
211). Differential efficiencies of genetic targeting and overall 
differences in the genetic ablation models may partly account for 
these discrepancies.
Recently, an additional role for autophagy proteins in the main-
tenance of CD8+ memory T cells has emerged. Mice that lack Atg7 
in T cells showed reduced CD8+ T cell-dependent recall responses 
upon infection with influenza and MCMV (212). Impairment of 
CD8+ T cell memory in elderly individuals is commonly observed 
and in part responsible for the reduced efficacy of vaccination with 
aging (213). Interestingly, Puleston et al. also found reduced levels 
of autophagic activity in CD8+ cells of aged mice. Accordingly, 
upregulation of autophagy with the polyamine spermidine could 
restore memory CD8+ T cell function to vaccination in aged mice 
(212). In contrast to what Pua and colleagues had reported previ-
ously (206), another study described how CD8+ cells downregu-
late autophagic activity upon activation and during proliferation. 
This was followed by increased activity before the contraction 
phase. Absence of the autophagy proteins Atg5 and Atg7 lead to 
impaired formation of a CD8+ T cell memory pool. Moreover, 
metabolomics analysis disclosed mitochondrial fatty acid oxida-
tion to be dysfunctional in Atg7-deficient T cells at the transition 
to the memory phase (214).
Aside from the role of autophagy in T cell survival and homeo-
stasis, also CMA has been implicated in regulating CD4+ T cell 
responses. The negative regulators of TCR signaling, RCAN1, 
and Itch have been identified as substrates for CMA. Thereby, 
CMA-controlled degradation of these molecules fine-tunes T 
cell responses which is exemplified by the significant reduction 
in activation-induced proliferation of CD4+ T cells that lack 
LAMP-2A expression (215). Although so far, dysfunctional CMA 
in T cell has not been formally reported to occur in MS or its 
model systems it is known that mice lacking Itch are prone to 
develop a hyperactive T cell-driven systemic progressive autoim-
mune condition (216).
Similar to T cell development, B cells require autophagy both 
during development and maintenance in the periphery. Atg5-
deficient pro-B cells do not efficiently develop into pre-B cells, 
but instead, seem to die at increased frequencies of apoptosis 
(217). Altogether, these data suggest that highly proliferative 
lymphocyte compartments during development or in response 
to immune activation, as seen in autoimmune CNS conditions, 
require the autophagic machinery to efficiently mobilize nutrients 
and maintain cellular fitness. However, further studies are needed 
to clarify differential roles of autophagy pathways in lymphocyte 
subsets particularly in the context of T cell-driven autoimmunity.
AUTOPHAGY AND ANTiGeN 
PReSeNTATiON
Similar to other autoimmune diseases, HLA-DR and -DQ alleles 
within the HLA class II region on chromosome 6p21 are by far 
the strongest risk-conferring genes and are thought to account for 
10–60% of the genetic risk of MS (218). The size of the autoreac-
tive T cell pool is limited by mechanisms of tolerance; however, 
it is clear that potentially dangerous cells persist in the immune 
system of healthy individuals without causing damage. Although 
it is generally accepted that HLA class II molecules influence auto-
immune disease risk by regulating the emergence, activation, and 
expansion of autoreactive CD4+ T lymphocytes, our knowledge of 
how HLA class II-mediated antigen presentation confers risk for 
autoimmune diseases and regulates CD4+ T cell autoreactivity at 
the molecular level is incompletely understood (219, 220).
The cellular architecture of MS lesions is dynamic in its neu-
ropathological features including leukocyte composition (221). 
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Commonly, T cell infiltration occurs in two distinct waves (222, 
223). Initially, MS lesions are characterized by oligodendrocyte 
damage and commencing demyelination accompanied by 
microglia that show an activated phenotype. However, in these 
initial lesions lymphocytes are scarce. Thereupon progressive 
demyelination occurs, and myelin constituents are phagocytosed 
by microglia and other myeloid cells which ensues a dramatic T 
cell influx (224).
Onset of EAE is fully dependent on the presence of myelin-
specific TH cells and local reactivation of these pathogenic culprits 
is essential in developing CNS autoimmunity (198–202). To 
this effect, on-site presence and activity of CD11c+ APCs is an 
instrumental prerequisite for disease induction during the effec-
tor phase of EAE (199). Moreover, intravital 2-photon micros-
copy analyses revealed that during EAE, CD11c+ APCs show a 
strong proinflammatory phenotype, express a chemokine profile 
complementary to the chemokine receptor profile expressed 
on encephalitogenic T cells in the CNS and depict close spatial 
interactions with these lymphocytes. Hence, depletion of CD11c+ 
APCs abrogated enrichment of pathogenic T cells in the CNS and 
significantly alleviated disease course upon adoptive transfer EAE 
(225). Active MOG35–55 immunization of mice that lack expres-
sion of Atg7 in the CD11c+ compartment results in ameliorated 
EAE disease course (226). Therefore, further elucidation of the 
underlying molecular events that drive these cognate interactions 
between the triad of (CNS resident) APC, myelin antigen, and 
encephalitogenic T cell, might unveil new potential therapeutic 
objectives.
The classical MHC class II pathway, the MA pathway, and 
LAP are potential degradation pathways resulting in MHC class 
II presentation of self-antigens. The first compelling evidence for 
the existence of an endogenous MHC class II pathway came from 
a study on describing how the endogenous measles virus matrix 
and nucleocapsid protein-derived antigens could be presented to 
CD4+ T cells via MHC class II (227). Only 1 year later, Nuchtern 
et  al. confirmed these findings for yet another viral antigen by 
reporting the efficient loading of influenza A matrix protein-
derived peptides onto MHC class II (228). Further proof for the 
existence of endogenous MHC class II loading pathways was 
obtained through the direct analysis of peptides bound to MHC 
class II molecules. In fact, around 30% of natural ligands eluted 
from MHC class II molecules from a multitude of cell types were 
found to be derived from endogenous protein sources (229). In 
a next step, MA was newly identified as a pathway that delivers 
endogenous antigenic constituents into MIICs for subsequent 
recognition by CD4+ T cells (9, 10, 230). Interestingly, the abil-
ity to deliver endogenous antigens to MHC class II seems to 
be differentially relevant depending on the APC (231). MA is 
constitutively active in a variety of MHC class II positive APCs 
such as DCs and B cells (9, 230, 232) and can be induced follow-
ing immune stimulation of these cells through germline-encoded 
pattern-recognition receptors such as TLRs or inflammatory 
cytokines (233–235). Co-localization studies indicate that in 
professional APCs, autophagosomes frequently fuse with MIICs, 
and that experimental delivery of antigens to autophagosomes 
by targeting the autophagosomal membrane through fusion with 
LC3 results in robust recognition by antigen-specific CD4+ T 
cells (10, 232). Additionally, not only hematopoietic APCs but 
also thymic epithelial cells expend MA to generate endogenously 
derived MHC class II-bound peptides for positive selection of 
CD4+ T cells (236).
Nevertheless, myelin-derived candidate antigens are not 
known to be expressed in professional APCs therefore an intra-
cellular loading of these peptides onto MHC class II molecules in 
the context of CNS autoimmunity appears counterintuitive. LAP 
couples phagocytosis of extracellular solid cargo to key members 
of the autophagy machinery (179, 187). A prerequisite for LAP 
is the engagement of germline-encoded pattern-recognition 
receptors or Ptd-L-Ser receptors through phagocytosed material. 
The role of TLR signaling in the context of EAE has partly been 
investigated. TLR9 and, to some extend, TLR2 signaling mediates 
the pathogenicity of EAE, whereas TLR1- and 6-deficiency in 
mice did not have an impact on the development of active EAE 
(237, 238). Importantly, also adoptive transfer EAE-induction 
was dependent on TLR2 signaling, discarding the assumption 
that microbial-derived constituents in the adjuvant preparation 
during active EAE serve as ligands (238). Additionally, both 
studies showed that deficiency of the downstream TLR-signaling 
molecule myeloid differentiation primary response gene 88 
(MyD88) abrogates disease (237, 238).
Ample data demonstrate that oligodendrocyte injury and 
death represented by primary demyelination in absence of 
inflammatory infiltrates constitute early events in the disease 
course and are considered specific pathogenic features of MS 
(239). Sequential MRI analyses revealed that subtle changes in 
white matter areas can be detected prior to apparent lesions (240). 
Reduction of macromolecular material and a focal increase of 
free water could be detected as early as several months before 
the active lesion occurred. The study’s authors concluded that 
the reduction of magnetization exchange rate was likely to result 
from primary myelin injury (241). Furthermore, genome-wide 
epigenetic differences in the DNA methylation status have been 
reported between normal appearing white matter derived from 
MS patients and non-diseased control brains (242). The observed 
hypermethylation and subsequent diminished expression of loci 
in MS affected brains included genes that control oligodendro-
cyte survival (BCL2L2 and NDRG1), suggesting that augmented 
susceptibility to injury precedes inflammatory infiltration. 
Importantly, a recent study showed that oligodendrocyte death is 
sufficient to induce encephalitogenic T cell responses and subse-
quent neuroinflammation in vivo (243). It is therefore conceivable 
that primary death of oligodendrocytes of yet unknown cause 
leads to subsequent uptake of myelin-derived antigenic debris 
by CNS-resident APCs and the following mounting of a myelin-
specific adaptive response (244). The non-canonical autophagy 
pathway LAP may facilitate uptake and ensuing presentation of 
myelin protein-derived antigenic constituents, thus promoting 
local reactivation of encephalitogenic TH cells.
Particularly early MS lesions depict enhanced gene expression 
related to ROS production. The most pronounced changes were 
found for transcripts encoding subunits of the NADPH oxidase 
complex 2 (NOX2), i.e., CYBA, CYBB, and NCF1, supporting 
the concept of oxidative stress as a pivotal pathogenic factor par-
ticularly early during the disease. NOX2 complex expression is 
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detectable in up to 20% of myeloid cells, predominantly localized 
in areas of initial tissue damage at the edge of actively demyelinat-
ing lesions and is associated with the presence of CNS-infiltrating 
T cells suggesting that NOX2 expression by myeloid cells may 
contribute to CNS inflammation via recruitment or expansion 
of T cells within MS lesions (245). NOX2 is expressed in mac-
rophages, DCs, microglia, neutrophils, and eosinophils (246). In 
resting conditions, the enzyme complex is highly glycosylated and 
resides in intracellular secondary granules and, at lower amounts, 
in the plasma membrane. After a triggering event, its subunits 
gp91 and p22 are translocated to the plasma membrane at the site 
of the forming phagosome, and the cytosolic subunits (p40, p47, 
p67) are recruited to assemble the active NOX2 complex (247). 
NOX2 function, generation of ROS, has initially been linked to 
killing of intraphagosomal pathogens by providing the adequate 
environment for protease function. In professional APCs, whose 
principal function is to take up, process and present antigens in 
order to initiate and shape adaptive immune responses rather 
than pathogen killing or clearance of cell debris, NOX2 expres-
sion was shown to regulate antigen presentation due to its ability 
to control the level of antigen degradation by altering phagosomal 
pH levels (248). Indeed, DCs lacking NOX2 show enhanced 
phagosomal acidification and increased antigen degradation, 
resulting in impaired cross presentation (248). In addition to cell 
type-dependent tuning of phagosomal acidification, NOX2 has 
recently also been implicated in regulating serine and cysteine 
proteases (cathepsins B, L, and S) within phagosomes (249) 
and it has been suggested that increased hydrolysis of critical 
regions within the encephalitogenic MOG35–55 antigen by cysteine 
cathepsins in the early phagosome contribute to the reduced 
incidence and delayed onset of EAE reported in NOX2-deficient 
mice (250). It is conceivable that NOX2 as essential component 
of the non-canonical autophagy pathway LAP not only affects 
levels of phagosomal proteolysis as previously shown, but facili-
tates the induction of an alternative pathway for antigen loading 
onto MHC class II molecules, thereby contributing to CD4+ T 
cell-mediated augmentation of autoimmune CNS inflammation.
Altogether, the aforementioned studies suggest that the 
autophagic machinery could potentially contribute to the initia-
tion and maintenance of CD4+ T cell-driven CNS tissue injury 
through delivery of CD4+ T cell antigens into MIICs.
OUTLOOK: AUTOPHAGY PATHwAYS iN 
CNS AUTOiMMUNiTY BeYOND ANTiGeN 
PReSeNTATiON AND LYMPHOCYTe 
SURvivAL
There is a profound body of evidence showing that mitochondrial 
dysfunction is a commonly observed feature in active MS plaques 
(194, 251–253). In lesions of patients suffering from acute MS, 
immunohistochemical analyses revealed mitochondrial defects 
selectively in respiratory chain complex IV subunit COX-I. 
Mitochondrial damage was observed in oligodendrocytes and 
axons, but was not present in macrophages or microglia (251). 
Mitochondria, while being a primary source thereof, are at the 
same time particularly susceptible to free radical-mediated 
damage and respiratory chain complex IV subunit COX-I expres-
sion is in part regulated by posttranslational modification of 
mRNA by nitric oxide (NO) (254–256). It has been suggested that 
myeloid cell-derived secretion of active mediators including NO 
in close proximity to oligodendrocytes mediates selective COX-I 
degradation with subsequent mitochondria impairment (221, 
257–260). NMDA-receptor signaling has been shown to induce 
NADPH oxidase (NOX) activity in oligodendrocyte precursor 
cells and the subsequent production of ROS can drive both fur-
ther oligodendrocyte differentiation and myelination (261, 262).
Malregulated oligodendrocyte-intrinsic events may also 
contribute to ROS-mediated mitochondrial damage in oligo-
dendrocytes during MS. Mitochondrial homeostasis (mitostasis) 
and quality control is ensured by consecutive cycles of fusion 
and fission tightly coupled to mitophagy-mediated removal of 
aberrant organelles (263, 264) and, complex IV deficiency as 
well as concomitant cellular energy deficit can in part be com-
pensated for by mitochondrial hyperfusion (265). It is therefore 
conceivable that malfunctioning of the autophagic axis within 
this regulatory network leads to disturbance of compensatory 
mechanisms during free radical induced COX-I deficiency (194, 
263). Interestingly, as opposed to the observed functional and 
morphological impairment of mitochondria in highly active 
lesions, older and inactive lesions depict enhanced mitochondrial 
count and activity (266, 267).
In comparison to other cell types, neurons depict an unique 
geometry and organelles such as mitochondria are also needed 
in distal axonal regions afar from the neuronal soma where 
mitophagy-mediated lysosomal degradation takes place (268, 
269). Duly distribution of mitochondria within axons is critical for 
neuronal physiology and the constant turnover of dysfunctional 
specimens in these post-mitotic cells requires well-regulated 
motor-protein-driven trafficking and anchoring of mitochondria 
alongside microtubules (269). Temporary increase in mitochon-
dria number, size, and activity as well as subcellular re-location 
is believed to constitute an axonoprotective mechanism in the 
light of an elevated energy consumption during chronic axonal 
injury (270). This compensatory mitochondrial response relies 
on anchoring molecule syntaphilin, which mediates docking 
of mitochondria through interaction with microtubules since 
knockout of syntaphilin results in exacerbated degeneration of 
demyelinated neurons (270). Syntaphilin-anchored mitochon-
dria have been reported to also recruit Parkin for subsequent 
mitophagy (268).
In addition to COX-I deficiency observed in acute MS lesions 
of the white matter, progressive disease also features mitochon-
drial alterations in deeper cortical areas reminiscent of prototypic 
neurodegenerative disorders with autophagy-associated pathoe-
tiology such as Alzheimer’s disease (AD) and Parkinson’s  disease 
(271, 272). Patients suffering from SPMS show significantly 
higher levels of clonally expanded mtDNA deletions in neurons 
of layer VI as compared to age-matched controls (272). Increased 
clonally expanded mtDNA deletions were also observed in layer 
VI adjacent subcortical white matter which suggests that in both 
instances soluble factors such as inflammation-associated free 
radicals in active lesions mediate mitochondrial degeneration. 
Although this needs to be clearly addressed experimentally, the 
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possibility has been raised that accumulations of mtDNA dele-
tions during MS might also yield mutations that could compro-
mise autophagy-mediated quality control of mitochondria (194).
In the process of ATP generation by mitochondrial oxidative 
phosphorylation, ROS arise that in order to maintain cellular 
integrity and to prevent oxidative stress, need to be eliminated 
by means of several antioxidants such as NADPH, cytochrome 
c, and most importantly glutathione (273). However, aside from 
their detrimental role when produced in large quantities, if not 
exceedingly present, ROS, occupy also important signaling func-
tions within the cell, interact with redox-sensitive proteins, and 
work toward maintaining cellular homeostasis in response to 
cell stress (274). Also Atgs have been described to be sensitive 
to ROS-mediated posttranslational modification. For example, 
Atg4 is oxidized and thereby inactivated by H2O2, which sub-
sequently facilitates conjugation of LC3 to membranes (275). 
Furthermore, redox-sensitive nuclear transcription factor and 
histone deacetylase sirtuin 1 (SIRT1), which is highly expressed 
in neurons, promotes autophagic activity directly by complexing 
and deacetylation of essential autophagy-machinery proteins and 
indirectly by deacetylation of FoxO members which in turn leads 
to promotion of autophagy (274, 276).
Portending oxidative damage, strong immunoreactivity for 
oxidized phospholipids in neurons of active cortical MS lesions 
has been described to be specific to MS and was not observed 
to the same degree in tuberculous meningitis, AD, and age-
matched controls (239). In accordance with these observations, 
antioxidant enzymes such as superoxide dismutase 1 and 2, heme 
oxigenase 1, and catalase have been shown to be increased in 
active MS lesions. Interestingly, this upregulation of antioxidant 
defense molecules was particularly present in astrocytes and 
myelin-containing macrophages but not in oligodendrocytes 
(277). It has been suggested before that the extreme susceptibil-
ity of oligodendrocytes to ROS-mediated damage is in part due 
to insufficient compensatory expression of protective enzymes 
(277, 278).
Increased mitochondrial-derived ROS accumulation and 
concomitant oxidative damage is believed to constitute a key 
feature of cellular aging and this process appears to be accelerated 
and augmented during MS particularly in oligodendrocytes and 
neurons (239, 279, 280). In line with this, treatment of aged mice 
with mTORC1 inhibitor and MA inducer rapamycin increased 
longevity in mice (281). It is likely that at least in part this effect 
was mediated by the compound’s capability to bridle injurious 
mitochondrial ROS production and mtDNA accumulation per 
induction of mitophagy (282).
Whole organelles such as mitochondria are not targeted 
for lysosomal degradation via LAMP-2A-dependent CMA. 
However, during cell stress, CMA does participate indirectly 
in mitochondrial quality control in neurons by removing non-
functional PARK7, a redox-sensitive glycase with antioxidative 
properties (283).
In order to target autophagy pathways for therapeutic pur-
poses in MS it will be crucial to fully elucidate the degree to which 
individual pathways (e.g., MI, MA, CMA, and LAP) contribute to 
pathology. This will be challenging since impairment of one path-
way may lead to both, compensatory responses and concomitant 
attenuation in the remaining pathways (145). To this end, robust 
methods need to be established in order reliably distinguish 
and monitor discrete autophagy pathways. Taken together, 
these data suggest that regenerative and protective processes in 
oligodendrocytes and demyelinated axons are highly reliant on 
meticulously functioning mitochondrial quality control, during 
which autophagic pathways play a pivotal role (194, 269). Future 
research will show whether the autophagic machinery, in addi-
tion to its function in regulating innate and adaptive immune 
responses, interferes with neurobiological features of MS such as 
axonal degeneration.
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